Table 2. Meningococcal monovalent C vaccines16,19,95.
A | ||||
---|---|---|---|---|
Formulation | Type | Trade name | Manufacturer | Serogroup |
MCC-TT | Conjugate | Neisvac-C | Baxter Healthcare | C |
MCC-CRM | Conjugate | Menjugate Kit | Novartis | |
MCC-CRM | Conjugate | Meningitec | Pfizer |
B | ||
---|---|---|
Licensed year | Age group | Dose (s) |
1999 | 2–4 mo | 3 |
1999–2000 | 5–11 mo | 2 |
1999–2000 | 1–18 y | 1 |
2002 | 20–24 y | 1 |
2006 | 12 mo | 1 (with Hib) |